KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Net Cash Flow (2016 - 2025)

Globus Medical's Net Cash Flow history spans 15 years, with the latest figure at $150.4 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 9.4% year-over-year to $150.4 million; the TTM value through Dec 2025 reached -$280.7 million, down 188.59%, while the annual FY2025 figure was -$280.7 million, 188.59% down from the prior year.
  • Net Cash Flow reached $150.4 million in Q4 2025 per GMED's latest filing, up from $141.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $208.3 million in Q3 2024 to a low of -$326.7 million in Q1 2025.
  • Average Net Cash Flow over 5 years is $13.2 million, with a median of $44.7 million recorded in 2022.
  • The largest YoY upside for Net Cash Flow was 7584.31% in 2021 against a maximum downside of 1341.24% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at -$168.6 million in 2021, then surged by 110.13% to $17.1 million in 2022, then surged by 1000.68% to $188.0 million in 2023, then decreased by 11.74% to $166.0 million in 2024, then fell by 9.4% to $150.4 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Net Cash Flow are $150.4 million (Q4 2025), $141.8 million (Q3 2025), and -$246.2 million (Q2 2025).